Cannabis Science, Inc. (OTCMKTS:CBIS) takes advantage of its unique understanding of metabolic processes to provide innovative treatment options for unmet medical needs.
![](/images/buts/googleplus-social.png)
![](/images/buts/twitter-social.png)
![](/images/buts/facebook-social.png)
![](/images/buts/linkedin-social.png)
![](/images/buts/heroes_alert_button.jpg)
In an article published on Forbes last week, Hemp-derived cannabidiol (CBD) is projected to be a billion-dollar market in just three years, according to a new report by Brightfield Group.